Xcellerex is revolutionizing the way biotherapeutics & vaccines
are developed, manufactured & commercialized.

Utilizing a breakthrough disposables-based technology platform and a novel suite of single-use biomanufacturing and process development products and services, Xcellerex partners with biopharm developers to deliver unrivaled production advantages, while also leveraging the platform to build a portfolio of proprietary biomolecules.

Technology Platform

Technology Platform

Recent News:

Cellon, S.A. to represent Xcellerex in key European markets more

Parrish Galliher to be featured speaker on three expert panels at BIO 2008 more

Parrish Galliher to Speak at 6th Annual Biodefense Vaccines & Therapeutics Conference more

Is Today's Biomanufacturing Model Broken?